CDK1 and central nervous system cancer: Western blot analysis showed elevated levels of cell cycle proteins B1, Cdk1, and pY15 after treatment, suggesting that compound 110’s antitumor activity in glioma may be due to its interference with the G2/M checkpoint, presenting a promising new direction for glioma therapies.